Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 1415

Showing 1-25 of 1415 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3370
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2187-2201
Open Access | Times Cited: 2358
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally, Eduan Wilkinson, Marta Giovanetti, et al.
Nature (2021) Vol. 592, Iss. 7854, pp. 438-443
Open Access | Times Cited: 1674
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy, et al.
Nature (2020) Vol. 588, Iss. 7839, pp. 682-687
Open Access | Times Cited: 1659
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, et al.
Nature (2021) Vol. 591, Iss. 7851, pp. 639-644
Open Access | Times Cited: 1584
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Nature (2021) Vol. 592, Iss. 7855, pp. 616-622
Open Access | Times Cited: 1438
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, et al.
Science (2021) Vol. 372, Iss. 6544, pp. 815-821
Open Access | Times Cited: 1435
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 622-625
Open Access | Times Cited: 1233
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1212
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
Houriiyah Tegally, Eduan Wilkinson, Marta Giovanetti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1178
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 654-656
Open Access | Times Cited: 1078
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe (2020) Vol. 29, Iss. 1, pp. 44-57.e9
Open Access | Times Cited: 1062
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen, Xianwen Zhang, James Brett Case, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 717-726
Open Access | Times Cited: 970
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A. Lempp, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2332-2347.e16
Open Access | Times Cited: 936
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 477-488.e4
Open Access | Times Cited: 809
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
Kelvin Kai‐Wang To, Ivan Fan‐Ngai Hung, Jonathan Daniel Ip, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 9, pp. e2946-e2951
Open Access | Times Cited: 771
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman, Caryn Hale, Yuhki Saito, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2212-2218
Open Access | Times Cited: 744
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Zijun Wang, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 595, Iss. 7867, pp. 426-431
Open Access | Times Cited: 742
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas, Timothée Bruel, Ludivine Grzelak, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 917-924
Closed Access | Times Cited: 732
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier, Anna De Marco, Isabella A. T. M. Ferreira, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 136-141
Open Access | Times Cited: 692
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway, Prabasaj Paul, Duncan MacCannell, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 3, pp. 95-99
Open Access | Times Cited: 687
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Sandile Cele, Inbal Gazy, Laurelle Jackson, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 142-146
Open Access | Times Cited: 680
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Emma C. Thomson, Laura E. Rosen, James G. Shepherd, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1171-1187.e20
Open Access | Times Cited: 623
Page 1 - Next Page

Scroll to top